Sales are an essential catalyst to the share prices of U.S. stocks. To illustrate this point, a 4.3% growth in the S&P 500’s total sales over the past five years resulted in a 67% rise in its price, which closed at $3,329.62 on Monday.

The following stocks have outperformed the benchmark for the U.S. market in terms of higher sales growth over the past five years, posting large returns in the 130% to 218% range.

Since these companies have already achieved remarkable increases in total sales, they may potentially continue to increase their top lines in the years to come,

According to GuruFocus' list of 52-week highs, these Guru stocks have reached their 52-Week Highs.

Steris PLC (STE) reached the 52-week high of $151.73

Steris PLC operates in four segments: healthcare products, healthcare specialty services, life sciences, and applied sterilization technologies. The healthcare products segment generates the majority of revenue and offers infection prevention equipment and consumables for healthcare providers. The healthcare specialty services segment provides services such as hospital sterilization, instrument repairs, and linen management. The life sciences segment provides equipment, consumables, and maintenance services to pharmaceutical manufacturers and research facilities. The applied sterilization technologies

Mallinckrodt PLC (MNK) is splitting up. But will that make either of the divorcees more appealing to investors?

Current shareholders certainly hope so. At about $22, the company’s shares are where they were 12 months hence and just a fraction of the $130 they traded for just two-and-a-half years earlier.

Mallinckrodt hoped less would be more when it announced plans Dec. 6 to spin off its specialty generics business to shareholders in 2019. That is, if it can’t find a buyer for it. So far, two interested parties have taken a look and decided to pass. Either they didn’t like

The All-in-One Screener can be used to find insider buys and sells over the last week by clicking on the Insiders tab and changing the settings for All Insider Buying to “$200,000+”, duration to "September 2016” and “September 2016” and All Insider Sales to “$5,000,000+”.

According to the above filters, the following are recent buys and sells from company insiders in the past week.

On Sept. 8, Felix Baker, director and part-owner of Seattle Genetics Inc. (SGEN), bought 414,016 shares at the price of $48.43 per share. Since then, the price of the stock has risen by 4.3%

Throughout the second quarter, gurus and mutual funds bought and sold stocks trading in American, European and Asian markets. Spiros Segalas (Trades, Portfolio), manager of Harbor Capital Appreciation Fund, mainly trades within the U.S. market while two other funds predominantly invest in European and Asian stocks.

Harbor Capital Appreciation Fund

Segalas, president and chief investment officer of Jennison Associates LLC, started the Capital Appreciation Fund Dec. 29, 1987. Since inception, the fund realized average annual total returns of 11.13%. To formulate his winning investment strategy, Segalas scrutinizes a company’s historical balance sheets and earnings performance. The Jennison